Inhalant intoxication
292.89 Inhalant Intoxication
Refer, in addition, to the text and criteria for Substance Intoxication (see p. 199). The essential feature of Inhalant Intoxication is the presence of clinically significant maladaptive behavioral or psychological changes (e.g., confusion, belligerence, assaultiveness, apathy, impaired judgment, impaired social or occupational functioning) that develop during, or shortly after, the intentional use of, or short-term, high-dose exposure to, volatile inhalants (Criteria A and B). The maladaptive changes are accompanied by signs that include dizziness or visual disturbances (blurred vision or diplopia), nystagmus, incoordination, slurred speech, an unsteady gait, tremor, and euphoria. Higher doses of inhalants may lead to the development of lethargy and psychomotor retardation, generalized muscle weakness, depressed reflexes, stupor, or coma (Criterion C). The disturbance must not be due to a general medical condition and is not better accounted for by another mental disorder (Criterion D).
Diagnostic criteria for 292.89 Inhalant Intoxication
- Recent intentional use or short-term, high-dose exposure to volatile inhalants (excluding anesthetic gases and short-acting vasodilators).
- Clinically significant maladaptive behavioral or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment, impaired social or occupational functioning) that developed during, or shortly after, use of or exposure to volatile inhalants.
- Two (or more) of the following signs, developing during, or shortly after, inhalant use or exposure:
- dizziness
- nystagmus
- incoordination
- slurred speech
- unsteady gait
- lethargy
- depressed reflexes
- psychomotor retardation
- tremor
- generalized muscle weakness
- blurred vision or diplopia
- stupor or coma
- euphoria
- The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.